| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.25B | +17.7% |
| Cost of Revenue | $984.2M | +17.1% |
| Gross Profit | $2.26B | +17.9% |
| R&D Expense | $523.0M | +21.3% |
| SG&A Expense | $888.7M | +13.7% |
| Operating Income | -$206.3M | +80.3% |
| Interest Expense | $32.9M | +47.3% |
| Pre-tax Income | -$203.9M | +80.3% |
| Income Tax | $4.1M | +155.6% |
| Net Income | -$207.9M | +79.8% |
| EPS (Basic) | -$1.10 | +80.3% |
| EPS (Diluted) | -$1.10 | +80.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $956.0M | +59.1% |
| Short-term Investments | $8.7M | -98.0% |
| Accounts Receivable | $298.7M | +20.0% |
| Inventory | $166.2M | +2.4% |
| Current Assets | $1.56B | -1.0% |
| Total Assets | $5.86B | -1.1% |
| Current Liabilities | $641.2M | -12.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $491.4M | +133.4% |
| Capital Expenditures | $134.7M | -1.0% |
| Investing Cash Flow | $195.1M | +144.1% |
| Financing Cash Flow | -$338.1M | -245.8% |
| Free Cash Flow | $356.8M | +378.6% |
| Total Liabilities |
| $3.46B |
| -1.9% |
| Stockholders' Equity | $2.40B | -0.0% |